Correction to: npj Vaccines 10.1038/s41541-021-00364-x, published online 17 August 2021.
In this article the author name Attila Farsang was incorrectly written as Atilla Farsang. The original article has been corrected.
. 2021 Nov 2;6:134. doi: 10.1038/s41541-021-00398-1
Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers
Kwinten Sliepen
1, Edith Schermer
1, Ilja Bontjer
1, Judith A Burger
1, Réka Felfödiné Lévai
2, Philipp Mundsperger
3, Philip J M Brouwer
1, Monica Tolazzi
4, Attila Farsang
2, Dietmar Katinger
3, John P Moore
5, Gabriella Scarlatti
4, Robin J Shattock
6, Quentin J Sattentau
7, Rogier W Sanders
1,5,✉
Kwinten Sliepen
1Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Find articles by Kwinten Sliepen
Edith Schermer
1Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Find articles by Edith Schermer
Ilja Bontjer
1Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Find articles by Ilja Bontjer
Judith A Burger
1Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Find articles by Judith A Burger
Réka Felfödiné Lévai
2Control Laboratory of Veterinary Medicinal Products and Animal Facility, Directorate of Veterinary Medicinal Products, National Food Chain Safety Office, Budapest, Hungary
Find articles by Réka Felfödiné Lévai
Philipp Mundsperger
3Polymun Scientific Immunbiologische Forschung GmbH, Klosterneuburg, Austria
Find articles by Philipp Mundsperger
Philip J M Brouwer
1Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Find articles by Philip J M Brouwer
Monica Tolazzi
4Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
Find articles by Monica Tolazzi
Attila Farsang
2Control Laboratory of Veterinary Medicinal Products and Animal Facility, Directorate of Veterinary Medicinal Products, National Food Chain Safety Office, Budapest, Hungary
Find articles by Attila Farsang
Dietmar Katinger
3Polymun Scientific Immunbiologische Forschung GmbH, Klosterneuburg, Austria
Find articles by Dietmar Katinger
John P Moore
5Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY USA
Find articles by John P Moore
Gabriella Scarlatti
4Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
Find articles by Gabriella Scarlatti
Robin J Shattock
6Imperial College London, Department of Medicine, Division of Infectious Diseases, Section of Virology, Norfolk Place, London, W21PG UK
Find articles by Robin J Shattock
Quentin J Sattentau
7The Sir William Dunn School of Pathology, The University of Oxford, Oxford, OX13RE UK
Find articles by Quentin J Sattentau
Rogier W Sanders
1Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
5Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY USA
Find articles by Rogier W Sanders
1Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
2Control Laboratory of Veterinary Medicinal Products and Animal Facility, Directorate of Veterinary Medicinal Products, National Food Chain Safety Office, Budapest, Hungary
3Polymun Scientific Immunbiologische Forschung GmbH, Klosterneuburg, Austria
4Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
5Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY USA
6Imperial College London, Department of Medicine, Division of Infectious Diseases, Section of Virology, Norfolk Place, London, W21PG UK
7The Sir William Dunn School of Pathology, The University of Oxford, Oxford, OX13RE UK
✉
Corresponding author.
Collection date 2021.
Subject terms: Adjuvants, Recombinant vaccine, Protein vaccines, HIV infections
© The Author(s) 2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC8563773 PMID: 34728634
This corrects the article "Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers", 103.